We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

58 hedge funds and large institutions have $71.6M invested in Abeona Therapeutics in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

28% more call options, than puts

Call options by funds: $132K | Put options by funds: $103K

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

7% more funds holding

Funds holding: 54 → 58 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.05% less ownership

Funds ownership: 1.49% → 1.43% (-0.05%)

1% less capital invested

Capital invested by funds: $72M → $71.6M (-$459K)

Holders
58
Holders Change
+4
Holders Change %
+7.41%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
15
Reduced
13
Closed
7
Calls
$132K
Puts
$103K
Net Calls
+$29K
Net Calls Change
+$41K

Top Buyers

Rank Fund Capital Flow
1
CHP
Castle Hook Partners
New York
+$1.88M
2
JGC
J. Goldman & Co
New York
+$1.47M
3
BlackRock
BlackRock
New York
+$1.33M
4
HCM
Highbridge Capital Management
New York
+$670K
5
Goldman Sachs
Goldman Sachs
New York
+$537K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$5.54M
2
PA
Perceptive Advisors
New York
-$1.13M
3
Jennison Associates
Jennison Associates
New York
-$686K
4
OM
Opaleye Management
Massachusetts
-$645K
5
CAM
Cormorant Asset Management
Massachusetts
-$516K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$11.7M – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$9.75M – – –
BBA
3
Baker Bros. Advisors
New York
$8.42M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.86M +$309K +2,399 +7%
SFM
5
Soros Fund Management
New York
$4.48M – – –
CHP
6
Castle Hook Partners
New York
$3.57M +$1.88M +14,600 +104%
HCM
7
Highbridge Capital Management
New York
$3.41M +$670K +5,192 +24%
PA
8
Perceptive Advisors
New York
$3.11M -$1.13M -8,772 -26%
NC
9
Nexthera Capital
New York
$2.47M -$384K -2,980 -13%
CAM
10
Cormorant Asset Management
Massachusetts
$2M -$516K -4,000 -20%
KAM
11
Kavi Asset Management
New York
$1.83M – – –
Millennium Management
12
Millennium Management
New York
$1.7M -$421K -3,264 -19%
RA
13
Royce & Associates
New York
$1.56M – – –
JGC
14
J. Goldman & Co
New York
$1.42M +$1.47M +11,376 New
OM
15
Opaleye Management
Massachusetts
$1.38M -$645K -5,000 -31%
BlackRock
16
BlackRock
New York
$1.29M +$1.33M +10,300 New
Wellington Management Group
17
Wellington Management Group
Massachusetts
$1.02M +$156K +1,212 +17%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$980K +$23.7K +184 +2%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$866K +$495K +3,836 +124%
MCM
20
Moore Capital Management
New York
$750K – – –
Allianz Asset Management
21
Allianz Asset Management
Germany
$631K +$401K +3,107 +160%
Goldman Sachs
22
Goldman Sachs
New York
$580K +$537K +4,162 +871%
Morgan Stanley
23
Morgan Stanley
New York
$523K +$519K +4,027 +2,549%
DCM
24
DAFNA Capital Management
California
$338K -$47.8K -371 -12%
CT
25
Cambridge Trust
Massachusetts
$327K – – –
1
2 3

ABEO Hedge Fund Activity: Q1 2017 in Review

58 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2017, worth a combined $71.6M — down 0.64% from $72M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ABEO positions and 7 closed out — a net gain of 7 holders — while 15 added to existing stakes and 13 trimmed.

The largest buyer was Castle Hook Partners, adding an estimated $1.88M. The largest seller was RA Capital Management, exiting entirely with an estimated $5.54M sold.

  • 58 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2017, up from 54 in Q4 2016.
  • Funds reported $71.6M of Abeona Therapeutics stock for Q1 2017, down 0.64% quarter-over-quarter.
  • 14 funds opened new Abeona Therapeutics positions in Q1 2017 and 7 closed out, a net change of +7 holders.
  • The largest Abeona Therapeutics buyer in Q1 2017 was Castle Hook Partners, an estimated $1.88M added.
  • The largest Abeona Therapeutics seller in Q1 2017 was RA Capital Management, an estimated $5.54M sold.

Based on aggregated 13F filings for Q1 2017.